“Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, pp. 458-62, https://doi.org/10.25251/skin.6.6.2.